An observational study in Patient Readmission, sponsored by Getúlio Vargas University Hospital. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-17.
Sponsored by Getúlio Vargas University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Postoperative Complications with a site in Brazil — 8 open to participants now, 8 under way, none of them phase 3. Postoperative Complications · Brazil.
Among the 36 studies in Postoperative Complications with a site in Brazil, this one is the 7th largest by planned enrollment of the 11 observational ones that give a count, is one of 3 that started in 2026, is one of 11 observational ones, and was the 35th registered.
1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.
Browse Postoperative Complications studies →8 of the 36 studies in Postoperative Complications with a site in Brazil are open now. Recruiting first, the newest first:
Federal University of Minas Gerais · Sites in Brazil
Ages 18+
Hospital de Clinicas de Porto Alegre · Sites in Brazil
Ages 18+
Hospital Nossa Senhora da Conceicao · Sites in Brazil
Ages 18+
University of Sao Paulo · Sites in Brazil
Ages 18+ · Healthy volunteers
University of Sao Paulo · Sites in Brazil
Ages 1 days–18 yrs
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 251 across 541 observational studies indexed under Postoperative Complications.
Median enrollment 118 across the 25 interventional studies, 362 across the 11 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 36 has an industry lead sponsor. The 10 most frequent:
Getúlio Vargas University Hospital is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Getúlio Vargas University Hospital has 1 study filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
2 of the studies in Postoperative Complications with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07675421Federal University of Minas GeraisImpact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer | 2027-08-31 |
| NCT06953128Hospital de Clinicas de Porto AlegreGeneral Versus Regional Anesthesia in Peripheral Arterial Surgery | 2027-11-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 36 studies in Postoperative Complications with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Hospital readmissions are an important measure of healthcare quality and safety. These events create a substantial burden for patients, families, and health systems because they may increase costs, extend recovery time, and lead to more serious postoperative complications. Predicting which patients are at higher risk of readmission remains difficult, as many complications begin silently and are not easily identified in routine clinical evaluations.
This study aims to evaluate whether artificial intelligence (AI) can help predict hospital readmissions in surgical patients by analyzing physiological and behavioral data collected before and after surgery. To achieve this, participants will use wearable devices-specifically a smartwatch and a smart ring-capable of continuously monitoring health biomarkers such as heart rate, electrocardiogram (ECG), oxygen saturation, sleep patterns, blood pressure trends, body composition through bioimpedance, and stress indicators. These devices are provided through a technology partnership and sponsorship from Samsung, which supports the study with advanced health technologies.
This is a prospective, single-center cohort study conducted at the main tertiary hospital in the state of Amazonas. Approximately 225 to 300 adults undergoing medium- or large-scale elective surgeries will be invited to participate over a 25-month period. All participants will provide informed consent. After enrollment, the study will collect demographic information, preoperative assessments, validated sleep questionnaires, comorbidity indexes such as the Charlson Comorbidity Index, laboratory exams, pulmonary function tests, intraoperative and postoperative data, and hospital discharge information.
Participants will be continuously monitored using wearable devices during their hospital stay-including the first 48 hours in the intensive care unit when applicable-and for 30 days after hospital discharge. These physiological data will be integrated with clinical and laboratory information to create a comprehensive dataset.
The primary objective is to develop and test artificial intelligence models capable of predicting 30-day hospital readmission following elective surgery. Both deep learning approaches and classical machine-learning techniques will be evaluated. By analyzing large volumes of continuous physiologic data, these models may identify early signs of postoperative deterioration that would otherwise go unnoticed.
If successful, this study may improve postoperative care, support earlier clinical intervention, reduce complications, and help healthcare teams provide safer recovery pathways for surgical patients.
Hospital readmissions are well established as key indicators of healthcare quality, particularly in the postoperative setting. Unplanned readmissions often reflect complications that were not fully predicted or adequately managed, generating substantial financial and clinical burden for health systems. In the United States, 3.8 million adult readmissions occurred within 30 days in 2018, with an average cost of US$15,200 per event. In Brazil, similarly high readmission rates have been reported, with 13.4% of more than 22,000 hospitalizations resulting in return visits, largely due to hospital infection, obstructive sleep apnea, and cardiac arrhythmias. Sleep disturbances-including obstructive sleep apnea-are among the most significant contributors to postoperative complications and readmissions. They delay recovery, increase pain sensitivity, impair cognition, and elevate cardiovascular risk. Vascular comorbidities such as hypertension, diabetes, and hyperlipidemia further worsen outcomes by increasing the likelihood of ischemic events, impaired wound healing, and respiratory instability. Understanding how physiologic, behavioral, and sleep-related variables interact to influence postoperative recovery is essential for designing early detection and prevention strategies.
Artificial intelligence (AI) has shown increasing promise in predicting clinical deterioration and identifying high-risk patients across multiple surgical fields. A recent systematic review of 26 studies demonstrated that AI-based models-including natural language processing, classical machine-learning algorithms, and deep learning methods-can accurately predict hospital readmissions following major surgery. However, most available datasets do not combine preoperative, intraoperative, postoperative, and continuous physiologic signals collected in real time from wearable devices, representing a major gap in the literature. This prospective cohort study aims to address this gap by integrating high-resolution physiologic and behavioral data captured from wearable devices-specifically smartwatches and smart rings-into a unified perioperative database, with the overarching goal of developing AI models capable of predicting unplanned hospital readmissions within 30 days after surgery.
The study seeks to build a comprehensive database of patients undergoing medium- to large-scale elective surgeries, capturing physiologic and behavioral data from wearables and multiparametric monitors during the pre- and post-operative periods, including continuous monitoring in the first 48 hours of intensive care when indicated. Data collection will include continuous wearable monitoring via a web-based interface developed by CETELI/UFAM, pre- and post-operative clinical assessments, laboratory tests, imaging studies, pulmonary function evaluations, polysomnography, and validated sleep questionnaires. The study will evaluate correlations between physiologic and sleep-related variables derived from smartwatches and smart rings and the risk of hospital readmission.
Additionally, the study will develop applications for smartwatch and smart ring use in perioperative data capture and employ machine learning approaches-including deep architectures such as causal convolutional networks and recurrent neural networks, as well as classical methods such as support vector machines and decision trees-to predict hospital readmissions. Associations between wearable-derived sleep parameters and 30-day readmission risk will be analyzed, pre- and post-operative sleep data will be correlated with polysomnography and questionnaire results, and sleep quality will be compared between preoperative and post-operative periods.
This research is conducted through a multidisciplinary collaboration between the Hospital Universitário Getúlio Vargas (HUGV-UFAM/Ebserh), and the Center for Research and Development in Electronic and Information Technology (CETELI/UFAM). CETELI will be responsible for developing the data-collection software, storage architecture, and predictive algorithms, while clinical oversight, recruitment, and protocol execution will be led by HUGV.
Beyond scientific relevance, this project has significant practical importance. In geographically complex regions such as the Amazon, continuous remote monitoring using wearable devices can enhance follow-up, reduce disparities in access to postoperative care, and enable earlier identification of complications. Integrating AI-based prediction models with hospital workflows may ultimately reduce costs, optimize patient flow, and improve the safety and quality of surgical care.
The study population will consist of adult patients scheduled for medium- and large-scale elective surgeries at the Hospital Universitário Getúlio Vargas, a tertiary referral center in Amazonas. Patients are initially evaluated at the affiliated outpatient clinic, Ambulatório Araújo Lima. Eligible individuals will be invited to participate during preoperative consultations with the attending surgeon, approximately 15 days before hospital admission. Study procedures, information delivery, and informed consent will be conducted by the surgical specialists responsible for outpatient care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Non-inclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
30-day hospital readmission
Occurrence of any unplanned hospital readmission within 30 days after discharge following medium- and large-scale surgical procedures. The outcome is binary (Yes/No).
Time frame: Within 30 days post-surgery
Length of hospital stay
Total number of days from hospital admission to discharge following the surgical procedure.
Time frame: From hospital admission through hospital discharge, up to postoperative day 10
Need for reoperation
Any surgical reintervention required during hospitalization or within the 30-day post-operative period.
Time frame: Up to 30 days after surgery
Number of Participants With Surgical Site Infection
Time frame: Up to 30 days post-surgery (or up to hospital discharge if earlier)
30-day mortality
All-cause death occurring within 30 days after the surgical procedure.
Time frame: Up to 30 days post-surgery
Subjective Sleep Quality Assessed by the Pittsburgh Sleep Quality Index (PSQI) Total Score
Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI) total score, which ranges from 0 to 21, with higher scores indicating worse sleep quality.
Time frame: Pre-operative baseline (2 days before admission) and post-operative follow-up at 14 days after hospital discharge.
Insomnia Severity Assessed by the Insomnia Severity Index (ISI) Total Score
Insomnia severity will be assessed using the Insomnia Severity Index (ISI) total score, which ranges from 0 to 28, with higher scores indicating more severe insomnia
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Risk of Sleep-Disordered Breathing Assessed by the Neck, Obesity, Snoring, Age, Sex (NoSAS) Score
Risk of sleep-disordered breathing will be assessed using the Neck, Obesity, Snoring, Age, Sex (NoSAS) score, which ranges from 0 to 17, with higher scores indicating a higher risk of sleep-disordered breathing.
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Daytime Sleepiness Assessed by the Epworth Sleepiness Scale (ESS) Total Score
Daytime sleepiness will be assessed using the Epworth Sleepiness Scale (ESS) total score, which ranges from 0 to 24, with higher scores indicating greater daytime sleepiness.
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Total Sleep Time Assessed by Polysomnography
Total sleep time measured in minutes using overnight polysomnography.
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Sleep Efficiency Assessed by Polysomnography
Sleep efficiency measured as a percentage (%) using overnight polysomnography.
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Sleep Latency Assessed by Polysomnography
Sleep latency measured in minutes using overnight polysomnography.
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Wake After Sleep Onset Assessed by Polysomnography
Wake after sleep onset measured in minutes using overnight polysomnography.
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Apnea-Hypopnea Index Assessed by Polysomnography
Apnea-Hypopnea Index (AHI), measured as the number of events per hour of sleep using overnight polysomnography. Higher values indicate more severe sleep-disordered breathing
Time frame: Pre-operative baseline (2 days before hospital admission) and post-operative follow-up at 14 days after hospital discharge.
Plan to share: No
Started Mar 2026 (actual). Primary completion is estimated for Aug 2026, 5 months after the start.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 5 months is below that.
Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Getúlio Vargas University Hospital